The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Surface markers of lymphocyte activation and markers of cell proliferation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Rejection of the Kidney Allograft
Nankivell, B. J., & Alexander, S. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0902927 · Cited by 605
Research works printed but not linked: 82
- Waki, 2006, UNOS Liver Registry: ten year survivals, Clin Transpl, 29
- Kaneku, 2006, Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry, Clin Transpl, 1
- Srinivas, 2008, Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result, Clin J Am Soc Nephrol, S101, 10.2215/CJN.03510807 · doi:10.2215/cjn.03510807
- Meier-Kriesche, 2004, Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era, Am J Transplant, 4, 378, 10.1111/j.1600-6143.2004.00332.x · DOI · Paper page
- Wieland, 2010, Biomarkers as a tool for management of immunosuppression in transplant patients, Ther Drug Monit, 32, 560, 10.1097/FTD.0b013e3181efb3d2 · DOI
- Bharat, 2007, Allopeptides and the alloimmune response, Cell Immunol, 248, 31, 10.1016/j.cellimm.2007.03.010 · DOI
- El-Sawy, 2002, Chemokines: directing leukocyte infiltration into allografts, Curr Opin Immunol, 14, 562, 10.1016/S0952-7915(02)00382-5 · DOI
- Barrett, 2003, New developments in allotransplant immunology, Hematology Am Soc Hematol Educ Program, 102, 350, 10.1182/asheducation-2003.1.350 · DOI
- Wucherpfennig, 2007, Polyspecificity of T cell and B cell receptor recognition, Semin Immunol, 19, 216, 10.1016/j.smim.2007.02.012 · DOI · Paper page
- Pasare, 2005, Toll-like receptors: linking innate and adaptive immunity, Adv Exp Med Biol, 560, 11, 10.1007/0-387-24180-9_2 · DOI · Paper page
- Kabelitz, 2007, Expression and function of Toll-like receptors in T lymphocytes, Curr Opin Immunol, 19, 39, 10.1016/j.coi.2006.11.007 · DOI · Paper page
- Raedler, 2010, Complement regulation of T-cell alloimmunity, Curr Opin Organ Transplant, 16, 54, 10.1097/MOT.0b013e3283425419 · DOI
- Suárez-Alvarez, 2009, Potential role of NKG2D and its ligands in organ transplantation: new target for immunointervention, Am J Transplant, 9, 251, 10.1111/j.1600-6143.2008.02526.x · doi:10.1111/j.1600-6143.2008.02526.x
- Yu, 2006, NK cells promote transplant tolerance by killing donor antigen-presenting cells, J Exp Med, 203, 1851, 10.1084/jem.20060603 · DOI · Paper page
- Clathworthy, 2011, Targeting B cells and antibody in transplantation, Am J Transplant, 11, 1359, 10.1111/j.1600-6143.2011.03554.x · DOI · Paper page
- Csencsits, 2003, Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction, Am J Transplant, 3, 107, 10.1034/j.1600-6143.2003.00036.x · DOI
- Häyry, 1994, Molecular pathology of acute and chronic rejection, Transplant Proc, 26, 3280
- Chatila, 1989, Mechanisms of T cell activation by the calcium ionophore ionomycin, J Immunol, 143, 1283, 10.4049/jimmunol.143.4.1283 · DOI · Paper page
- Zarling, 1976, A sensitive micromethod for generating and assaying allogeneically induced cytotoxic human lymphocytes, Transplantation, 21, 468, 10.1097/00007890-197606000-00005 · doi:10.1097/00007890-197606000-00005
- Trickett, 2003, T cell stimulation and expansion using anti-CD3/CD28 beads, J Immunol Methods, 275, 251, 10.1016/S0022-1759(03)00010-3 · DOI · Paper page
- Barten, 2001, Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro, J Immunol Methods, 253, 95, 10.1016/S0022-1759(01)00369-6 · DOI
- Leonardi, 1992, PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables, J Clin Pathol, 45, 416, 10.1136/jcp.45.5.416 · DOI · Paper page
- Palutke, 1989, A method for measuring lymphocyte proliferation in mixed lymphocyte cultures using a nuclear proliferation antigen, Ki-67, and flow cytometry, Am J Clin Pathol, 91, 417, 10.1093/ajcp/91.4.417 · doi:10.1093/ajcp/91.4.417
- Schlegel, 1997, The role of adhesion and costimulation molecules in graft-versus-host disease, Acta Haematol, 97, 105, 10.1159/000203666 · doi:10.1159/000203666
- Testi, 1989, T cell activation via Leu-23 (CD69), J Immunol, 143, 1123, 10.4049/jimmunol.143.4.1123 · DOI · Paper page
- Hintzen, 1995, Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation, J Immunol, 154, 2612, 10.4049/jimmunol.154.6.2612 · DOI · Paper page
- Schuurman, 1989, Expression of activation antigens on thymocytes in the ‘common thymocyte’ stage of differentiation, Thymus, 14, 43
- Miyawaki, 1992, Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood, J Immunol, 149, 3753, 10.4049/jimmunol.149.11.3753 · DOI · Paper page
- Li, 2009, Costimulatory pathways in transplantation: challenges and new developments, Immunol Rev, 229, 271, 10.1111/j.1600-065X.2009.00781.x · DOI · Paper page
- Ohnuma, 2008, Role of CD26/dipeptidyl peptidase IV in human T cell activation and function, Front Biosci, 13, 2299, 10.2741/2844 · DOI
- Ibegbu, 2009, Differential expression of CD26 on virus-specific CD8+ T cells during active, latent and resolved infection, Imunology, 126, 346, 10.1111/j.1365-2567.2008.02899.x · DOI
- Heemann, 1994, Adhesion molecules and transplantation, Ann Surg, 219, 4, 10.1097/00000658-199401000-00002 · DOI
- Tan, 2005, Chemokine receptors and transplantation, Cell Mol Immunol, 2, 343
- Holling, 2004, Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men, Hum Immunol, 65, 282, 10.1016/j.humimm.2004.01.005 · DOI · Paper page
- Boleslawski, 2011, CD28 expression by peripheral blood lymphocytes as a potential predictor of the development of de novo malignancies in long-term survivors after liver transplantation, Liver Transpl, 17, 299, 10.1002/lt.22232 · DOI
- Biselli, 1992, Multiparametric flow cytometric analysis of the kinetics of surface molecule expression after polyclonal activation of human peripheral blood T lymphocytes, Scand J Immunol, 35, 439, 10.1111/j.1365-3083.1992.tb02879.x · doi:10.1111/j.1365-3083.1992.tb02879.x
- Barten, 2004, Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood, Transplantation, 77, 1154, 10.1097/01.TP.0000120391.42712.E8 · doi:10.1097/01.tp.0000120391.42712.e8
- Niwa, 2009, Stimulation index for PCNA mRNA in peripheral blood as immune function monitoring after renal transplantation, Transplantation, 87, 1411, 10.1097/TP.0b013e3181a277bb · doi:10.1097/tp.0b013e3181a277bb
- Böhler, 1998, The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation, Transplant Proc, 30, 2195, 10.1016/S0041-1345(98)00588-0 · doi:10.1016/s0041-1345(98)00588-0
- Augustine, 2007, Comparison of ATP production in whole blood and lymphocyte proliferation in response to phytohemagglutinin, J Clin Lab Anal, 21, 265, 10.1002/jcla.20182 · doi:10.1002/jcla.20182
- Wu, 1991, Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation, Transplant Proc., 23, 238
- Shipkova, 2001, The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes, Transplant Proc, 33, 1080, 10.1016/S0041-1345(00)02424-6 · doi:10.1016/s0041-1345(00)02424-6
- Lyons, 1994, Determination of lymphocyte division by flow cytometry, J Immunol Methods, 71, 131, 10.1016/0022-1759(94)90236-4 · DOI · Paper page
- Babel, 2009, Lymphocyte markers and predicition of long-term renal allograft acceptance, Curr Opin Nephrol Hypertens, 18, 489, 10.1097/MNH.0b013e3283318f82 · DOI
- Böhler, 2007, Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans, Ther Drug Monit, 29, 77, 10.1097/FTD.0b013e318030a40b · DOI
- Dambrin, 2000, Pharmacodynamics of immunosuppressive drugs, Curr Opin Immunol, 12, 557, 10.1016/S0952-7915(00)00138-2 · doi:10.1016/s0952-7915(00)00138-2
- Kubbies, 1985, Cell cycle kinetics by BrdU-Hoechst flow cytometry: an alternative to the differential metaphase labeling, Cell Tissue Kinet, 18, 551
- Shaw, 1995, Analytic requirements for immunosuppressive drugs in clinical trials, Ther Drug Monit, 17, 577, 10.1097/00007691-199512000-00006 · doi:10.1097/00007691-199512000-00006
- Davis, 2011, Stability of immunophenotypic markers in fixed peripheral blood for extended analysis using flow cytometry, J Immunol Methods, 363, 158, 10.1016/j.jim.2010.09.029 · DOI
- Fletcher, 1987, Use of whole blood methods in assessment of immune parameters in immunodeficiency states, Diagn Clin Immunol, 5, 69
- Rainen, 2002, Stabilization of mRNA expression in whole blood samples, Clin Chem, 48, 1883, 10.1093/clinchem/48.11.1883 · DOI · Paper page
- Wieland, 2011, Association between pharmacodynamic biomarkers and clinical events in the early phase after kidney transplantation: a single-center pilot study, Ther Drug Monit, 33, 341, 10.1097/FTD.0b013e3182188675 · doi:10.1097/ftd.0b013e3182188675
- Berry, 2006, Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses, Cytometry A, 69, 95, 10.1002/cyto.a.20200 · doi:10.1002/cyto.a.20200
- Wang, 2007, The unexpected effect of cyclosporin A on CD56+CD16− and CD56+CD16+ natural killer cell subpopulations, Blood, 110, 1530, 10.1182/blood-2006-10-048173 · DOI
- Barten, 2003, Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood, J Immunol Methods, 283, 99, 10.1016/j.jim.2003.08.015 · doi:10.1016/j.jim.2003.08.015
- Shipkova, 2009, Effect of immunosuppressants on CD26/dipetidyl peptidase IV expression on CD3 in vitro, Ther Drug Monit, 31, 660
- He, 2011, Mycophenolic acid-mediated suppression of human CD4+ T cells: more than mere guanine nucleotide deprivation, Am J Transplant, 11, 439, 10.1111/j.1600-6143.2010.03413.x · DOI
- Sindhi, 2003, Modeling individual variation in biomarker response to combination immunosuppression with stimulated lymphocyte responses-potential clinical implications, J Immunol Methods, 272, 257, 10.1016/S0022-1759(02)00326-5 · doi:10.1016/s0022-1759(02)00326-5
- Van Rijen, 2003, Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor- and tumour necrosis factor-receptor superfamily costimulatory molecules, Immunology, 109, 109, 10.1046/j.1365-2567.2003.01635.x · doi:10.1046/j.1365-2567.2003.01635.x
- Stalder, 2003, Quantification of immunosuppression by flow cytometry in stable renal transplant recipients, Ther Drug Monit, 25, 22, 10.1097/00007691-200302000-00003 · doi:10.1097/00007691-200302000-00003
- Prémaud, 2011, Inibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships, Pharmacol Res, 63, 432, 10.1016/j.phrs.2011.01.005 · doi:10.1016/j.phrs.2011.01.005
- Kamar, 2009, Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation, Clin J Am Soc Nephrol, 4, 936, 10.2215/CJN.04860908 · doi:10.2215/cjn.04860908
- Hutchinson, 2003, Laboratory assessment of immune function in renal transplant patients, Nephrol Dial Transplant, 18, 983, 10.1093/ndt/gfg190 · doi:10.1093/ndt/gfg190
- Böhler, 2008, Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients, Int Immunopharmacol, 8, 769, 10.1016/j.intimp.2008.01.023 · doi:10.1016/j.intimp.2008.01.023
- Weigel, 2001, Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients, J Heart Lung Transplant, 21, 1074, 10.1016/S1053-2498(02)00440-0 · DOI
- Canivet, 2008, T-cell function in maintenance renal transplant patients receiving mycophenolate mofetil and steroids with or without tacrolimus, Transpl Proc, 40, 3422, 10.1016/j.transproceed.2008.06.062 · doi:10.1016/j.transproceed.2008.06.062
- Barten, 2005, Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients, Transplant Proc, 37, 4532, 10.1016/j.transproceed.2005.10.091 · doi:10.1016/j.transproceed.2005.10.091
- Barten, 2007, Pharmacodynamics of T-cell function for monitoring immunosuppression, Cell Prolif, 40, 50, 10.1111/j.1365-2184.2007.00413.x · doi:10.1111/j.1365-2184.2007.00413.x
- Morteau, 2010, Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo, PLoS One, 12, e13294, 10.1371/journal.pone.0013294 · DOI
- Deng, 1998, T-cell and monocyte subsets, inflammatory molecules, rejection, and hemodynamics early after cardiac transplantation, Transplantation, 65, 1255, 10.1097/00007890-199805150-00018 · DOI
- Beik, 1998, Serial flow cytometric analysis of T-cell surface markers can be useful in differential diagnosis of renal allograft dysfunction, Clin Transplant, 12, 24, 10.1111/j.1399-0012.1998.tb01064.x · doi:10.1111/j.1399-0012.1998.tb01064.x
- Chang, 1996, Cytokines and cell surface markers in prediction of cardiac allograft rejection, Immunol Invest, 25, 13, 10.3109/08820139609059287 · doi:10.3109/08820139609059287
- Boleslawski, 2008, CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation, Clin Transplant, 22, 494, 10.1111/j.1399-0012.2008.00815.x · doi:10.1111/j.1399-0012.2008.00815.x
- Roberti, 2001, Serial evaluation of cell surface markers for immune activation after acute renal allograft rejection by urine flow cytometry—correlation with clinical outcome, Transplantation, 71, 1317, 10.1097/00007890-200105150-00024 · doi:10.1097/00007890-200105150-00024
- Sindhi, 2005, Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early liver rejection, Am J Transplant, 5, 96, 10.1111/j.1600-6143.2004.00639.x · doi:10.1111/j.1600-6143.2004.00639.x
- Sindhi, 2005, Reduced immunosuppression in pediatric liver-intestine transplant recipients with CD8+CD28− T-suppressor cells, Hum Immunol, 66, 252, 10.1016/j.humimm.2004.05.017 · DOI
- Ashokkumar, 2010, Allospecific CD154+ B cells associate with intestine allograft rejection in children, Transplantation, 90, 1226, 10.1097/TP.0b013e3181f995ce · DOI
- Ashokkumar, 2009, Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation, Am J Transplant, 9, 179, 10.1111/j.1600-6143.2008.02459.x · DOI
- Millán, 2010, Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy, Clin Immunol, 137, 337, 10.1016/j.clim.2010.08.004 · DOI
- Latek, 2009, Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation, Transplantation, 87, 926, 10.1097/TP.0b013e31819b5a58 · DOI
- Newell, 2010, Identification of a B cell signature associated with renal transplant tolerance in humans, J Clin Invest, 120, 1836, 10.1172/JCI39933 · DOI · Paper page
- Sagoo, 2010, Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans, J Clin Invest, 120, 1848, 10.1172/JCI39922 · DOI · Paper page
Cited by
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
Shifrut, E., Carnevale, J., Tobin, V., Roth, T. L., Woo, J. M., Bui, C. T., Li, P. J., Diolaiti, M. E., Ashworth, A., & Marson, A. (2018) · Cell · doi:10.1016/j.cell.2018.10.024 · Cited by 573
Effector, Memory, and Dysfunctional CD8+T Cell Fates in the Antitumor Immune Response
Reiser, J., & Banerjee, A. (2016) · Journal of Immunology Research · doi:10.1155/2016/8941260 · Cited by 255
Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
Chandler, L. C., McClements, M. E., Yusuf, I. H., Martinez-Fernandez de la Camara, C., MacLaren, R. E., & Xue, K. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.011 · Cited by 43
“, CD69, CD25, and CD70) and pro-inflammatory cytokines may be helpful.(34)”
Background
Metadata
- Authors
- Shipkova, M., & Wieland, E.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 413
- Issue
- 17-18
- Pages
- 1338-1349
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2007190645
- Cited by
- 210
- References
- 2
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Surface markers of lymphocyte activation and markers of cell proliferation. https://app.cochat.ai/papers/10.1016/j.cca.2011.11.006
- The paper
- Shipkova, M., & Wieland, E. (2012). Surface markers of lymphocyte activation and markers of cell proliferation. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2011.11.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.